Antigen
Vendor:
First CVE: Dec 31, 2004 · Active for 21 years
2
Total CVEs
More Total CVEs than 53% of tracked products
1.0
Avg CVEs / Year
Bottom 1%
5.0
Avg CVSS
Higher Avg CVSS than 9% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Antigen over time
Volume of CVEsAvg CVSS Base Score
First CVE
Dec 31, 2004
21 years ago
Most Recent CVE
Sep 21, 2005
7,615 days ago
CVE Severity & Scoring
Antigen2 CVEs
100%
All CVEs353,173 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network0 (0.0%)
Unknown2 (100.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low0 (0.0%)
High0 (0.0%)
Unknown2 (100.0%)
User Interaction
None0 (0.0%)
Unknown2 (100.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None0 (0.0%)
Unknown2 (100.0%)
Top CVEs
Signals from CVEs in this product scope (2 CVEs).
2 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2005-3027MEDIUM Sybari Antigen 8.0 SR2 does not properly filter SMTP messages, which allows remote attackers to bypass custom filter rules and send file attachments of arbitrary file types via a m | Sep 21, 2005 | 5.0 | 15 | NO | NO |
CVE-2004-2348MEDIUM Sybari AntiGen for Domino 7.0 Build 722 SR2 allows remote attackers to cause a denial of service (hang) via an encrypted ZIP file with the "include full path info" option set, as u | Dec 31, 2004 | 5.0 | 15 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (2 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (2 CVEs).
Media Mentions
Signals from CVEs in this product scope (2 CVEs).
Top CNAs Publishing CVEs For Antigen
Versions
| Version | CVE Count | Avg CVSS | Avg EPSS | KEV | Exploits |
|---|---|---|---|---|---|
| 8.0 | 1 | 5.0 | 1.5% | 0 | 0 |
| 7.0_build_722_\(sr2\) | 1 | 5.0 | 1.6% | 0 | 0 |